Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination

Postgrad Med J. 2022 Feb 7:postgradmedj-2022-141510. doi: 10.1136/postmj/postgradmedj-2022-141510. Online ahead of print.

Authors

Adrian Y S Lee^{1

2

3}, Caroline Lee¹, David A Brown^{1

2

3}, Dan Suan^{1

3}

Affiliations

¹ Westmead Hospital, Westmead, New South Wales, Australia.
² Department of Immunopathology, Institute for Clinical Pathology and Medical Research & NSW Health Pathology, Westmead, NSW, Australia.
³ Westmead Clinical School, The University of Sydney, Westmead, NSW, Australia.

PMID: 37076766
DOI: 10.1136/postmj/postgradmedj-2022-141510

No abstract available

Keywords: adult dermatology; immunology; neurology; rheumatology.